Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders

BACKGROUND: Atriplex laciniata L. was investigated for phenolic, flavonoid contents, antioxidant, anticholinesterase activities, in an attempt to explore its effectiveness in Alzheimer's and other neurological disorders. Plant crude methanolic extract (Al.MeF), subsequent fractions; n-hexane (A...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kamal,Zul, Ullah,Farhat, Ayaz,Muhammad, Sadiq,Abdul, Ahmad,Sajjad, Zeb,Anwar, Hussain,Abid, Imran,Muhammad
Lenguaje:English
Publicado: Sociedad de Biología de Chile 2015
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602015000100021
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0716-97602015000100021
record_format dspace
spelling oai:scielo:S0716-976020150001000212016-02-16Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disordersKamal,ZulUllah,FarhatAyaz,MuhammadSadiq,AbdulAhmad,SajjadZeb,AnwarHussain,AbidImran,Muhammad Phenolic & flavonoid contents DPPH ABTS H2O2 Gallic acid IC50 and anticholinesterase BACKGROUND: Atriplex laciniata L. was investigated for phenolic, flavonoid contents, antioxidant, anticholinesterase activities, in an attempt to explore its effectiveness in Alzheimer's and other neurological disorders. Plant crude methanolic extract (Al.MeF), subsequent fractions; n-hexane (Al.HxF), chloroform (Al.CfF), ethyl acetate (Al.EaF), aqueous (Al.WtF), Saponins (Al.SPF) and Flavonoids (Al.FLVF) were investigated for DPPH, ABTS and H2O2 free radical scavenging activities. Further these extracts were subjected to acetylcholinesterase (AChE) & butyrylcholinesterase (BChE) inhibitory activities using Ellman's assay. Phenolic and Flavonoid contents were determined and expressed in mg Gallic acid GAE/g and Rutin RTE/g of samples respectively. RESULTS: In DPPH free radicals scavenging assay, Al.FLVF, Al.SPF and Al.MeF showed highest activity causing 89.41 ± 0.55, 83.37 ± 0.34 and 83.37 ± 0.34% inhibition of free radicals respectively at 1 mg/mL concentration. IC50 for these fractions were 33, 83 and 82 μg/mL respectively. Similarly, plant extracts showed high ABTS scavenging potential, i.e. Al.FLVF (90.34 ± 0.55), Al.CfF (83.42 ± 0.57), Al.MeF (81.49 ± 0.60) with IC50 of 30, 190 and 70 μg/ml respectively. further, H2O2 percent scavenging was highly appraised in Al.FLVF (91.29 ±0.53, IC50 75), Al.SPF (85.35 ±0.61, IC50 70) and Al.EaF (83.48 ± 0.67, IC50 2 70 μg/mL). All fractions exhibited concentration dependent AChE inhibitory activity as; Al.FLVF, 88.31 ± 0.57 (IC50 70 μg/mL), Al.SPF, 84.36 ± 0.64 (IC50 90 μg/mL), Al.MeF, 78.65 ± 0.70 (IC50 2 80 μg/mL), Al.EaF, 77.45 ± 0.46 (IC50 2 70 μg/mL) and Al.WtF 72.44 ± 0.58 (IC50 2 63 μg/mL) at 1 mg/mL. Likewise the percent BChE inhibitory activity was most obvious in Al.FLVF 85.46 ± 0.62 (IC50 1 00 μg/mL), Al.CfF 83.49 ± 0.46 (IC50 160 μg/mL), Al.MeF 82.68 ± 0.60 (IC50 2 20 μg/mL) and Al.SPF 80.37 ± 0.54 (IC50 1 20 μg/mL. CONCLUSIONS: These results stipulate that A. laciniata is enriched with phenolic and flavonoid contents that possess significant antioxidant and anticholinestrase effects. This provide pharmacological basis for the presence of compounds that may be effective in Alzheimer's and other neurological disorders.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.48 20152015-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602015000100021en10.1186/s40659-015-0011-1
institution Scielo Chile
collection Scielo Chile
language English
topic Phenolic & flavonoid contents
DPPH
ABTS
H2O2
Gallic acid
IC50 and anticholinesterase
spellingShingle Phenolic & flavonoid contents
DPPH
ABTS
H2O2
Gallic acid
IC50 and anticholinesterase
Kamal,Zul
Ullah,Farhat
Ayaz,Muhammad
Sadiq,Abdul
Ahmad,Sajjad
Zeb,Anwar
Hussain,Abid
Imran,Muhammad
Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders
description BACKGROUND: Atriplex laciniata L. was investigated for phenolic, flavonoid contents, antioxidant, anticholinesterase activities, in an attempt to explore its effectiveness in Alzheimer's and other neurological disorders. Plant crude methanolic extract (Al.MeF), subsequent fractions; n-hexane (Al.HxF), chloroform (Al.CfF), ethyl acetate (Al.EaF), aqueous (Al.WtF), Saponins (Al.SPF) and Flavonoids (Al.FLVF) were investigated for DPPH, ABTS and H2O2 free radical scavenging activities. Further these extracts were subjected to acetylcholinesterase (AChE) & butyrylcholinesterase (BChE) inhibitory activities using Ellman's assay. Phenolic and Flavonoid contents were determined and expressed in mg Gallic acid GAE/g and Rutin RTE/g of samples respectively. RESULTS: In DPPH free radicals scavenging assay, Al.FLVF, Al.SPF and Al.MeF showed highest activity causing 89.41 ± 0.55, 83.37 ± 0.34 and 83.37 ± 0.34% inhibition of free radicals respectively at 1 mg/mL concentration. IC50 for these fractions were 33, 83 and 82 μg/mL respectively. Similarly, plant extracts showed high ABTS scavenging potential, i.e. Al.FLVF (90.34 ± 0.55), Al.CfF (83.42 ± 0.57), Al.MeF (81.49 ± 0.60) with IC50 of 30, 190 and 70 μg/ml respectively. further, H2O2 percent scavenging was highly appraised in Al.FLVF (91.29 ±0.53, IC50 75), Al.SPF (85.35 ±0.61, IC50 70) and Al.EaF (83.48 ± 0.67, IC50 2 70 μg/mL). All fractions exhibited concentration dependent AChE inhibitory activity as; Al.FLVF, 88.31 ± 0.57 (IC50 70 μg/mL), Al.SPF, 84.36 ± 0.64 (IC50 90 μg/mL), Al.MeF, 78.65 ± 0.70 (IC50 2 80 μg/mL), Al.EaF, 77.45 ± 0.46 (IC50 2 70 μg/mL) and Al.WtF 72.44 ± 0.58 (IC50 2 63 μg/mL) at 1 mg/mL. Likewise the percent BChE inhibitory activity was most obvious in Al.FLVF 85.46 ± 0.62 (IC50 1 00 μg/mL), Al.CfF 83.49 ± 0.46 (IC50 160 μg/mL), Al.MeF 82.68 ± 0.60 (IC50 2 20 μg/mL) and Al.SPF 80.37 ± 0.54 (IC50 1 20 μg/mL. CONCLUSIONS: These results stipulate that A. laciniata is enriched with phenolic and flavonoid contents that possess significant antioxidant and anticholinestrase effects. This provide pharmacological basis for the presence of compounds that may be effective in Alzheimer's and other neurological disorders.
author Kamal,Zul
Ullah,Farhat
Ayaz,Muhammad
Sadiq,Abdul
Ahmad,Sajjad
Zeb,Anwar
Hussain,Abid
Imran,Muhammad
author_facet Kamal,Zul
Ullah,Farhat
Ayaz,Muhammad
Sadiq,Abdul
Ahmad,Sajjad
Zeb,Anwar
Hussain,Abid
Imran,Muhammad
author_sort Kamal,Zul
title Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders
title_short Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders
title_full Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders
title_fullStr Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders
title_full_unstemmed Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders
title_sort anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata l.: potential effectiveness in alzheimer's and other neurological disorders
publisher Sociedad de Biología de Chile
publishDate 2015
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602015000100021
work_keys_str_mv AT kamalzul anticholinesterseandantioxidantinvestigationsofcrudeextractssubsequentfractionssaponinsandflavonoidsofatriplexlaciniatalpotentialeffectivenessinalzheimersandotherneurologicaldisorders
AT ullahfarhat anticholinesterseandantioxidantinvestigationsofcrudeextractssubsequentfractionssaponinsandflavonoidsofatriplexlaciniatalpotentialeffectivenessinalzheimersandotherneurologicaldisorders
AT ayazmuhammad anticholinesterseandantioxidantinvestigationsofcrudeextractssubsequentfractionssaponinsandflavonoidsofatriplexlaciniatalpotentialeffectivenessinalzheimersandotherneurologicaldisorders
AT sadiqabdul anticholinesterseandantioxidantinvestigationsofcrudeextractssubsequentfractionssaponinsandflavonoidsofatriplexlaciniatalpotentialeffectivenessinalzheimersandotherneurologicaldisorders
AT ahmadsajjad anticholinesterseandantioxidantinvestigationsofcrudeextractssubsequentfractionssaponinsandflavonoidsofatriplexlaciniatalpotentialeffectivenessinalzheimersandotherneurologicaldisorders
AT zebanwar anticholinesterseandantioxidantinvestigationsofcrudeextractssubsequentfractionssaponinsandflavonoidsofatriplexlaciniatalpotentialeffectivenessinalzheimersandotherneurologicaldisorders
AT hussainabid anticholinesterseandantioxidantinvestigationsofcrudeextractssubsequentfractionssaponinsandflavonoidsofatriplexlaciniatalpotentialeffectivenessinalzheimersandotherneurologicaldisorders
AT imranmuhammad anticholinesterseandantioxidantinvestigationsofcrudeextractssubsequentfractionssaponinsandflavonoidsofatriplexlaciniatalpotentialeffectivenessinalzheimersandotherneurologicaldisorders
_version_ 1718441532464300032